62.55

4.93% 2.94

After Hours: 62.10 -0.45 -0.72%

Disc Medicine Inc (IRON)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Disc Medicine Inc stock is traded at $62.55, with a volume of 466.81K. It is up +4.93% in the last 24 hours and down -6.49% over the past month. Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Previous Close:

$59.61

Open:

$60.85

24h Volume:

466.81K

Relative Volume:

0.64

Market Cap:

$2.39B

Revenue:

Net Income/Loss:

$-212.18M

P/E Ratio:

-10.44

EPS:

-5.9897

Net Cash Flow:

$-181.33M

1W Performance:

+5.77%

1M Performance:

-6.49%

6M Performance:

+0.08%

1Y Performance:

+18.49%

1-Day Range:

$59.97

$63.18

1-Week Range:

$57.72

$63.18

52-Week Range:

$30.82

$99.50

Disc Medicine Inc Stock (IRON) Company Profile

Name

Disc Medicine Inc

Sector

Healthcare (1114)

Industry

Biotechnology (623)

Phone

(617) 674-9274

Address

321 ARSENAL STREET, SUITE 101, WATERTOWN

Employee

155

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

IRON's Discussions on Twitter

Compare IRON vs VRTX, REGN, ALNY, ARGX, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
IRON Disc Medicine Inc	62.55	2.27B	0	-212.18M	-181.33M	-5.9897
VRTX Vertex Pharmaceuticals Inc	454.97	113.96B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	749.47	78.41B	14.34B	4.50B	3.77B	41.56
ALNY Alnylam Pharmaceuticals Inc	328.70	40.85B	3.71B	313.75M	465.38M	2.2571
ARGX Argen X Se Adr	697.05	42.05B	4.16B	1.29B	734.26M	19.58
INSM Insmed Inc	148.31	29.99B	606.42M	-1.28B	-997.58M	-6.403

Disc Medicine Inc Stock (IRON) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-03-25	Resumed	Stifel	Buy
Jul-21-25	Initiated	Truist	Buy
Jul-03-25	Resumed	Morgan Stanley	Overweight
Jun-11-25	Resumed	Raymond James	Strong Buy
Feb-27-25	Initiated	TD Cowen	Buy
Nov-05-24	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Nov-04-24	Upgrade	Raymond James	Outperform → Strong Buy
Oct-23-24	Initiated	Jefferies	Buy
Oct-16-24	Initiated	Scotiabank	Sector Outperform
Aug-22-24	Initiated	Wells Fargo	Overweight
Apr-01-24	Downgrade	Raymond James	Strong Buy → Outperform
Dec-19-23	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Jun-09-23	Upgrade	Raymond James	Outperform → Strong Buy
Jun-07-23	Initiated	H.C. Wainwright	Buy
May-17-23	Initiated	Raymond James	Outperform
Apr-28-23	Initiated	Cantor Fitzgerald	Overweight
Apr-21-23	Initiated	Stifel	Buy
Apr-20-23	Initiated	Morgan Stanley	Overweight
Mar-23-23	Initiated	BMO Capital Markets	Outperform
Feb-28-23	Initiated	SVB Securities	Outperform

View All

Disc Medicine Inc Stock (IRON) Latest News

Mar 25, 2026